ScholarLens Back to search
2013•Journal of Crohn s and ColitisOpen access

P106 Active macrophage migration inhibitory factor (MIF) is a previously unrecognized isoform of MIF and a potential new biomarker for inflammatory bowel diseases

Dirk Völkel, Michael Thiele, Patrice Douillard, Randolf J. Kerschbaumer, Fritz Scheiflinger, Hartmut J. Ehrlich, Herbert Tilg, Alexander Rupert Moschen

Open full text 0 citations

Abstract

D. Völkel, M. Thiele, P. Douillard, R. Kerschbaumer, F. Scheiflinger, H. Ehrlich, H. Tilg, A. Moschen; P106 Active macrophage migration inhibitory factor (

Open-access reader

About this research paper

What this paper is about

D. Völkel, M. Thiele, P. Douillard, R. Kerschbaumer, F. Scheiflinger, H. Ehrlich, H. Tilg, A. Moschen; P106 Active macrophage migration inhibitory factor (

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

D. Völkel, M. Thiele, P. Douillard, R. Kerschbaumer, F. Scheiflinger, H. Ehrlich, H. Tilg, A. Moschen; P106 Active macrophage migration inhibitory factor (

Key concepts: Macrophage migration inhibitory factor, Biomarker, Gene isoform, Inhibitory postsynaptic potential, Macrophage, Inflammatory bowel disease, Inflammation, Inflammatory Bowel Diseases

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
P106 Active macrophage migration inhibitory factor (MIF) is a previously unrecognized isoform of MIF and a potential new biomarker for inflammatory bowel diseases — Research Paper | ScholarLens